LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide

Yang Liu, Silke Walter, Massimiliano Stagi, Dmitry Cherny, Maryse Letiembre, Walter Schulz-Schaeffer, Holger Heine, B. Penke, Harald Neumann, Klaus Fassbender

Research output: Contribution to journalArticle

228 Citations (Scopus)

Abstract

The amyloid β peptide 42 (Aβ42) plays a key role in neurotoxicity in Alzheimer's disease. Mononuclear phagocytes, i.e. microglia, have the potential to clear Aβ by phagocytosis. Recently, the lipopolysaccharide (LPS) receptor CD14 was shown to mediate phagocytosis of bacterial components and furthermore to contribute to neuroinflammation in Alzheimer's disease. Here, we investigated whether this key innate immunity receptor can interact with Aβ42 and mediate phagocytosis of this peptide. Using flow cytometry, confocal microscopy and two-photon fluorescence lifetime imaging (FLIM) combined with fluorescence resonance energy transfer (FRET), we demonstrated a direct molecular interaction in the range of a few nanometers between Aβ42 and CD14 in human CD14-transfected Chinese hamster ovary cells. Investigations using cells that were genetically deficient for this receptor showed that in 42 added to cultured primary microglial cells was phagocytosed into the cytoplasmic compartment in a CD14-dependent manner. This phagocytosis occurred at Aβ42 concentration ranges that were considerably lower than the threshold to activate a cellular inflammatory reaction. In contrast, there was no association of CD14 to microglial internalization of microbeads. In complementary clinical experiments, we detected a pronounced CD14 immunoreactivity on parenchymal microglia spatially correlated to characteristic Alzheimer's disease lesion sites in brain sections of Alzheimer's disease patients but not in brain sections of control subjects. By showing a close interaction between CD14 and Aβ42, demonstrating a direct role of CD14 in Aβ42 phagocytosis, and detecting CD14-specific staining in brains of Alzheimer's disease patients, our results indicate a role of the LPS receptor in the pathophysiology of Alzheimer's disease, which could be of therapeutic relevance.

Original languageEnglish
Pages (from-to)1778-1789
Number of pages12
JournalBrain
Volume128
Issue number8
DOIs
Publication statusPublished - Aug 2005

Fingerprint

CD14 Antigens
Amyloid
Alzheimer Disease
Phagocytosis
Peptides
Microglia
Cytophagocytosis
Fluorescence Resonance Energy Transfer
Optical Imaging
Brain
Brain Diseases
Phagocytes
Cricetulus
phagocytosis receptor
Microspheres
Photons
Innate Immunity
Confocal Microscopy
Ovary
Flow Cytometry

Keywords

  • Alzheimer's disease
  • Amyloid β protein
  • CD14
  • Microglia
  • Phagocytosis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Liu, Y., Walter, S., Stagi, M., Cherny, D., Letiembre, M., Schulz-Schaeffer, W., ... Fassbender, K. (2005). LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide. Brain, 128(8), 1778-1789. https://doi.org/10.1093/brain/awh531

LPS receptor (CD14) : A receptor for phagocytosis of Alzheimer's amyloid peptide. / Liu, Yang; Walter, Silke; Stagi, Massimiliano; Cherny, Dmitry; Letiembre, Maryse; Schulz-Schaeffer, Walter; Heine, Holger; Penke, B.; Neumann, Harald; Fassbender, Klaus.

In: Brain, Vol. 128, No. 8, 08.2005, p. 1778-1789.

Research output: Contribution to journalArticle

Liu, Y, Walter, S, Stagi, M, Cherny, D, Letiembre, M, Schulz-Schaeffer, W, Heine, H, Penke, B, Neumann, H & Fassbender, K 2005, 'LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide', Brain, vol. 128, no. 8, pp. 1778-1789. https://doi.org/10.1093/brain/awh531
Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, Schulz-Schaeffer W et al. LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide. Brain. 2005 Aug;128(8):1778-1789. https://doi.org/10.1093/brain/awh531
Liu, Yang ; Walter, Silke ; Stagi, Massimiliano ; Cherny, Dmitry ; Letiembre, Maryse ; Schulz-Schaeffer, Walter ; Heine, Holger ; Penke, B. ; Neumann, Harald ; Fassbender, Klaus. / LPS receptor (CD14) : A receptor for phagocytosis of Alzheimer's amyloid peptide. In: Brain. 2005 ; Vol. 128, No. 8. pp. 1778-1789.
@article{d4d9df1f9c86424aade8c1a68ff988c5,
title = "LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide",
abstract = "The amyloid β peptide 42 (Aβ42) plays a key role in neurotoxicity in Alzheimer's disease. Mononuclear phagocytes, i.e. microglia, have the potential to clear Aβ by phagocytosis. Recently, the lipopolysaccharide (LPS) receptor CD14 was shown to mediate phagocytosis of bacterial components and furthermore to contribute to neuroinflammation in Alzheimer's disease. Here, we investigated whether this key innate immunity receptor can interact with Aβ42 and mediate phagocytosis of this peptide. Using flow cytometry, confocal microscopy and two-photon fluorescence lifetime imaging (FLIM) combined with fluorescence resonance energy transfer (FRET), we demonstrated a direct molecular interaction in the range of a few nanometers between Aβ42 and CD14 in human CD14-transfected Chinese hamster ovary cells. Investigations using cells that were genetically deficient for this receptor showed that in 42 added to cultured primary microglial cells was phagocytosed into the cytoplasmic compartment in a CD14-dependent manner. This phagocytosis occurred at Aβ42 concentration ranges that were considerably lower than the threshold to activate a cellular inflammatory reaction. In contrast, there was no association of CD14 to microglial internalization of microbeads. In complementary clinical experiments, we detected a pronounced CD14 immunoreactivity on parenchymal microglia spatially correlated to characteristic Alzheimer's disease lesion sites in brain sections of Alzheimer's disease patients but not in brain sections of control subjects. By showing a close interaction between CD14 and Aβ42, demonstrating a direct role of CD14 in Aβ42 phagocytosis, and detecting CD14-specific staining in brains of Alzheimer's disease patients, our results indicate a role of the LPS receptor in the pathophysiology of Alzheimer's disease, which could be of therapeutic relevance.",
keywords = "Alzheimer's disease, Amyloid β protein, CD14, Microglia, Phagocytosis",
author = "Yang Liu and Silke Walter and Massimiliano Stagi and Dmitry Cherny and Maryse Letiembre and Walter Schulz-Schaeffer and Holger Heine and B. Penke and Harald Neumann and Klaus Fassbender",
year = "2005",
month = "8",
doi = "10.1093/brain/awh531",
language = "English",
volume = "128",
pages = "1778--1789",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - LPS receptor (CD14)

T2 - A receptor for phagocytosis of Alzheimer's amyloid peptide

AU - Liu, Yang

AU - Walter, Silke

AU - Stagi, Massimiliano

AU - Cherny, Dmitry

AU - Letiembre, Maryse

AU - Schulz-Schaeffer, Walter

AU - Heine, Holger

AU - Penke, B.

AU - Neumann, Harald

AU - Fassbender, Klaus

PY - 2005/8

Y1 - 2005/8

N2 - The amyloid β peptide 42 (Aβ42) plays a key role in neurotoxicity in Alzheimer's disease. Mononuclear phagocytes, i.e. microglia, have the potential to clear Aβ by phagocytosis. Recently, the lipopolysaccharide (LPS) receptor CD14 was shown to mediate phagocytosis of bacterial components and furthermore to contribute to neuroinflammation in Alzheimer's disease. Here, we investigated whether this key innate immunity receptor can interact with Aβ42 and mediate phagocytosis of this peptide. Using flow cytometry, confocal microscopy and two-photon fluorescence lifetime imaging (FLIM) combined with fluorescence resonance energy transfer (FRET), we demonstrated a direct molecular interaction in the range of a few nanometers between Aβ42 and CD14 in human CD14-transfected Chinese hamster ovary cells. Investigations using cells that were genetically deficient for this receptor showed that in 42 added to cultured primary microglial cells was phagocytosed into the cytoplasmic compartment in a CD14-dependent manner. This phagocytosis occurred at Aβ42 concentration ranges that were considerably lower than the threshold to activate a cellular inflammatory reaction. In contrast, there was no association of CD14 to microglial internalization of microbeads. In complementary clinical experiments, we detected a pronounced CD14 immunoreactivity on parenchymal microglia spatially correlated to characteristic Alzheimer's disease lesion sites in brain sections of Alzheimer's disease patients but not in brain sections of control subjects. By showing a close interaction between CD14 and Aβ42, demonstrating a direct role of CD14 in Aβ42 phagocytosis, and detecting CD14-specific staining in brains of Alzheimer's disease patients, our results indicate a role of the LPS receptor in the pathophysiology of Alzheimer's disease, which could be of therapeutic relevance.

AB - The amyloid β peptide 42 (Aβ42) plays a key role in neurotoxicity in Alzheimer's disease. Mononuclear phagocytes, i.e. microglia, have the potential to clear Aβ by phagocytosis. Recently, the lipopolysaccharide (LPS) receptor CD14 was shown to mediate phagocytosis of bacterial components and furthermore to contribute to neuroinflammation in Alzheimer's disease. Here, we investigated whether this key innate immunity receptor can interact with Aβ42 and mediate phagocytosis of this peptide. Using flow cytometry, confocal microscopy and two-photon fluorescence lifetime imaging (FLIM) combined with fluorescence resonance energy transfer (FRET), we demonstrated a direct molecular interaction in the range of a few nanometers between Aβ42 and CD14 in human CD14-transfected Chinese hamster ovary cells. Investigations using cells that were genetically deficient for this receptor showed that in 42 added to cultured primary microglial cells was phagocytosed into the cytoplasmic compartment in a CD14-dependent manner. This phagocytosis occurred at Aβ42 concentration ranges that were considerably lower than the threshold to activate a cellular inflammatory reaction. In contrast, there was no association of CD14 to microglial internalization of microbeads. In complementary clinical experiments, we detected a pronounced CD14 immunoreactivity on parenchymal microglia spatially correlated to characteristic Alzheimer's disease lesion sites in brain sections of Alzheimer's disease patients but not in brain sections of control subjects. By showing a close interaction between CD14 and Aβ42, demonstrating a direct role of CD14 in Aβ42 phagocytosis, and detecting CD14-specific staining in brains of Alzheimer's disease patients, our results indicate a role of the LPS receptor in the pathophysiology of Alzheimer's disease, which could be of therapeutic relevance.

KW - Alzheimer's disease

KW - Amyloid β protein

KW - CD14

KW - Microglia

KW - Phagocytosis

UR - http://www.scopus.com/inward/record.url?scp=23444448277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444448277&partnerID=8YFLogxK

U2 - 10.1093/brain/awh531

DO - 10.1093/brain/awh531

M3 - Article

C2 - 15857927

AN - SCOPUS:23444448277

VL - 128

SP - 1778

EP - 1789

JO - Brain

JF - Brain

SN - 0006-8950

IS - 8

ER -